NashBio Therapeutic-Area Data Collections and Secure Research Platform

Nashville Biosciences (NashBio) is launching two new products designed to provide life science researchers, pharmaceutical companies, and biotech innovators with access to deidentified electronic health record (EHR) and linked genomic data for precision medicine research.

First, the company has launched therapeutic-area data collections, which are expertly curated, specialty-aligned datasets designed to make it easier to use complex clinical data features in high-priority therapeutic areas. By aligning high-quality EHR and genomic data with specific therapeutic needs scientists can find the best datasets for their research needs to bring innovative drugs and diagnostics to market faster, NashBio said.

In addition, in the spring of 2025, the company will launch its secure research platform, a scalable, cloud-based, data-as-a-service subscription platform that enables researchers to rapidly identify and analyze patient cohorts using disease-specific phenotypes, longitudinal clinical data, and genomic insights "on their own terms and timelines," the company said.